📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism. (2012)

First Author: Westendorf AF

Attributed to: Photoactivation strategies for delivery of platinum prodrugs; oxygen independent photodynamic therapy (PDT) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-11-0959

PubMed Identifier: 22710878

Publication URI: http://europepmc.org/abstract/MED/22710878

Type: Journal Article/Review

Volume: 11

Parent Publication: Molecular cancer therapeutics

Issue: 9

ISSN: 1535-7163